Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 459

1.

Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes.

Wang Y, Ye L, Wang X, Li J, Song L, Ho W.

Innate Immun. 2013;19(2):193-202. doi: 10.1177/1753425912460414. Epub 2012 Oct 11.

2.

Induction of interferon-λ contributes to Toll-like receptor-3-activated hepatic stellate cell-mediated hepatitis C virus inhibition in hepatocytes.

Wang Y, Li J, Wang X, Ye L, Zhou Y, Ho W.

J Viral Hepat. 2013 Jun;20(6):385-94. doi: 10.1111/jvh.12040. Epub 2013 Jan 7.

3.

Hepatitis C virus impairs TLR3 signaling and inhibits IFN-λ 1 expression in human hepatoma cell line.

Wang Y, Li J, Wang X, Ye L, Zhou Y, Thomas RM, Ho W.

Innate Immun. 2014 Jan;20(1):3-11. doi: 10.1177/1753425913478991. Epub 2013 Mar 25.

4.

Induction of interferon-λ contributes to TLR3 and RIG-I activation-mediated inhibition of herpes simplex virus type 2 replication in human cervical epithelial cells.

Zhou L, Li JL, Zhou Y, Liu JB, Zhuang K, Gao JF, Liu S, Sang M, Wu JG, Ho WZ.

Mol Hum Reprod. 2015 Dec;21(12):917-29. doi: 10.1093/molehr/gav058. Epub 2015 Oct 26.

5.

Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes.

Brownell J, Wagoner J, Lovelace ES, Thirstrup D, Mohar I, Smith W, Giugliano S, Li K, Crispe IN, Rosen HR, Polyak SJ.

J Hepatol. 2013 Oct;59(4):701-8. doi: 10.1016/j.jhep.2013.06.001. Epub 2013 Jun 12.

6.

Hepatitis C virus infection induces the beta interferon signaling pathway in immortalized human hepatocytes.

Kanda T, Steele R, Ray R, Ray RB.

J Virol. 2007 Nov;81(22):12375-81. Epub 2007 Sep 5.

7.

Toll-like receptor 3 and RIG-I-like receptor activation induces innate antiviral responses in mouse ovarian granulosa cells.

Yan K, Zhu W, Yu L, Li N, Zhang X, Liu P, Chen Q, Chen Y, Han D.

Mol Cell Endocrinol. 2013 Jun 15;372(1-2):73-85. doi: 10.1016/j.mce.2013.03.027. Epub 2013 Apr 6.

PMID:
23567548
8.

Immune activation of human brain microvascular endothelial cells inhibits HIV replication in macrophages.

Li J, Wang Y, Wang X, Ye L, Zhou Y, Persidsky Y, Ho W.

Blood. 2013 Apr 11;121(15):2934-42. doi: 10.1182/blood-2012-08-450353. Epub 2013 Feb 11.

9.

Expression of an IRF-3 fusion protein and mouse estrogen receptor, inhibits hepatitis C viral replication in RIG-I-deficient Huh 7.5 cells.

Yao L, Yan X, Dong H, Nelson DR, Liu C, Li X.

Virol J. 2011 Sep 21;8:445. doi: 10.1186/1743-422X-8-445.

10.

IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection.

Park H, Serti E, Eke O, Muchmore B, Prokunina-Olsson L, Capone S, Folgori A, Rehermann B.

Hepatology. 2012 Dec;56(6):2060-70. doi: 10.1002/hep.25897. Epub 2012 Nov 19.

11.

Restoration of the activated Rig-I pathway in hepatitis C virus (HCV) replicon cells by HCV protease, polymerase, and NS5A inhibitors in vitro at clinically relevant concentrations.

Kalkeri G, Lin C, Gopilan J, Sloan K, Rijnbrand R, Kwong AD.

Antimicrob Agents Chemother. 2013 Sep;57(9):4417-26. doi: 10.1128/AAC.00399-13. Epub 2013 Jul 8.

12.

EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.

Zhu C, Xiao F, Hong J, Wang K, Liu X, Cai D, Fusco DN, Zhao L, Jeong SW, Brisac C, Chusri P, Schaefer EA, Zhao H, Peng LF, Lin W, Chung RT.

J Virol. 2015 Jul;89(13):6608-18. doi: 10.1128/JVI.00364-15. Epub 2015 Apr 15.

13.

Hepatic stellate cells, liver innate immunity, and hepatitis C virus.

Wang Y, Li J, Wang X, Sang M, Ho W.

J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1:112-5. doi: 10.1111/jgh.12023. Review.

14.

HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection.

Israelow B, Narbus CM, Sourisseau M, Evans MJ.

Hepatology. 2014 Oct;60(4):1170-9. doi: 10.1002/hep.27227. Epub 2014 Aug 21.

15.

DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.

Grünvogel O, Esser-Nobis K, Reustle A, Schult P, Müller B, Metz P, Trippler M, Windisch MP, Frese M, Binder M, Fackler O, Bartenschlager R, Ruggieri A, Lohmann V.

J Virol. 2015 Oct;89(20):10548-68. doi: 10.1128/JVI.01297-15. Epub 2015 Aug 12.

16.

(-)-Epigallocatechin-3-Gallate Enhances Hepatitis C Virus Double-Stranded RNA Intermediates-Triggered Innate Immune Responses in Hepatocytes.

Wang Y, Li J, Wang X, Peña JC, Li K, Zhang T, Ho W.

Sci Rep. 2016 Feb 16;6:21595. doi: 10.1038/srep21595.

17.

Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length.

Kell A, Stoddard M, Li H, Marcotrigiano J, Shaw GM, Gale M Jr.

J Virol. 2015 Nov;89(21):11056-68. doi: 10.1128/JVI.01964-15. Epub 2015 Aug 26.

18.

Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication.

Wang B, Trippler M, Pei R, Lu M, Broering R, Gerken G, Schlaak JF.

J Hepatol. 2009 Dec;51(6):1037-45. doi: 10.1016/j.jhep.2009.06.020. Epub 2009 Jul 29.

PMID:
19716616
19.

Alcohol impairs interferon signaling and enhances full cycle hepatitis C virus JFH-1 infection of human hepatocytes.

Ye L, Wang S, Wang X, Zhou Y, Li J, Persidsky Y, Ho W.

Drug Alcohol Depend. 2010 Nov 1;112(1-2):107-16. doi: 10.1016/j.drugalcdep.2010.05.008. Epub 2010 Jun 20.

20.

Characterization of HCV interactions with Toll-like receptors and RIG-I in liver cells.

Eksioglu EA, Zhu H, Bayouth L, Bess J, Liu HY, Nelson DR, Liu C.

PLoS One. 2011;6(6):e21186. doi: 10.1371/journal.pone.0021186. Epub 2011 Jun 17.

Supplemental Content

Support Center